Engineers Gate Manager LP - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$2,855,126
+3.7%
176,788
+166.4%
0.11%
+1.9%
Q2 2023$2,754,397
+31.5%
66,371
+90.6%
0.10%
+18.2%
Q1 2023$2,094,556
+94.3%
34,828
+124.5%
0.09%
+120.0%
Q2 2022$1,078,000
+5.7%
15,512
+26.0%
0.04%0.0%
Q1 2022$1,020,000
-81.7%
12,308
-83.4%
0.04%
-84.1%
Q4 2021$5,579,000
+141.4%
74,310
+273.5%
0.25%
+90.2%
Q3 2021$2,311,000
+454.2%
19,895
+958.8%
0.13%
+388.9%
Q2 2021$417,000
-51.2%
1,879
-70.9%
0.03%
-35.7%
Q1 2021$854,000
-61.5%
6,461
-49.7%
0.04%
-56.2%
Q4 2020$2,221,000
-33.0%
12,837
-56.9%
0.10%
-38.1%
Q3 2020$3,314,000
+188.4%
29,774
+53.7%
0.16%
+167.2%
Q2 2020$1,149,000
-70.1%
19,370
-66.1%
0.06%
-79.1%
Q1 2020$3,844,000
+325.7%
57,078
+432.5%
0.28%
+592.5%
Q4 2019$903,000
+124.6%
10,719
+99.3%
0.04%
+100.0%
Q3 2019$402,000
-90.0%
5,378
-91.5%
0.02%
-91.0%
Q2 2019$4,015,000
-2.7%
63,505
-25.9%
0.22%
-11.2%
Q1 2019$4,127,000
+1368.7%
85,666
+1495.0%
0.25%
+1036.4%
Q3 2018$281,000
-85.1%
5,371
-91.1%
0.02%
-85.0%
Q2 2018$1,885,000
+37.4%
60,220
-11.3%
0.15%
+56.4%
Q4 2017$1,372,000
+207.6%
67,899
+202.3%
0.09%
+147.4%
Q3 2017$446,000
-70.6%
22,461
-74.4%
0.04%
-72.3%
Q2 2017$1,516,00087,6430.14%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders